Emtricitabine And Tenofovir Disoproxil Fumarate Tablet, Film Coated
Product Images NDC 67296-2198

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Emtricitabine And Tenofovir Disoproxil Fumarate (NDC 67296-2198). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Camber-logo (Camber Logo)

FDA Label Image

Cont-label (Cont Label)

Label for Emtricitabine and Tenofovir Disoproxil Fumarate Tablets 200 mg/300 mg film-coated tablets. The label includes dosing information, storage instructions, and pharmacist advisory. Manufactured for Camber Pharmaceuticals, Inc. and produced by Hetero Labs Limited, India. Package contains 30 tablets.*

FDA Label Image

Structure-1 (Structure 1)

Chemical structure of emtricitabine, part of the combination product emtricitabine and tenofovir disoproxil fumarate. The diagram shows the molecular arrangement including nitrogen, oxygen, fluorine, sulfur atoms, and ring structures typical of emtricitabine.*

FDA Label Image

Structure-2 (Structure 2)

Chemical structure of Emtricitabine and tenofovir disoproxil fumarate, showing the molecular arrangement including nitrogen-containing rings, phosphate group, and fumarate moiety.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.